katie sturino glp 1 Have you joined me for Lobby Coffee yet? My substack is where I dive deeper & get more vulnerable! Comment “☕️” and I'll DM you a link to read! For years, Katie Sturino, the

In the world of GLP-1 agonists, semaglutide has emerged as a noteworthy contender, often gaining attention due to its remarkable efficacy compared to other treatments

But proteins break down when they get too warm

veterans with type 2 diabetes found that GLP-1 receptor agonists, commonly used for diabetes and weight management, are associated with a reduced risk of developing substance use disorders across multiple substances

Furthermore, Tirzepatide has a greater affinity to GIP relative to GLP-1 receptors expressed on cells

There is some theoretical basis for this thinking

However, unlike FDA-approved GLP-1 medications, these patches arent regulated to the same public safety standards, and the claims made by manufacturers are not backed by the same degree of rigorous clinical trials